Leucadia Pharmaceuticals: generic injectable manufacturer 2018-02-27T19:06:51+00:00

A premier source for generic injectables

A new source for injectable pharmaceuticals—the supply you need, with the consistency and quality you demand.

About Leucadia Pharmaceuticals

At Leucadia Pharmaceuticals, we are set to be leaders in the generic injectables market. We’re investing heavily, expanding operations and scientific personnel, while also pursuing partnerships and product acquisitions. Our goal is to provide important new generic injectable products to the acute and specialty markets, and to reach communities and conditions that are under-served.

Leucadia Pharmaceuticals was established in 2015 as the commercial arm of Custopharm, Inc., and is associated with Water Street Healthcare Partners.

Sterile injectable generic drug products

Our injectables are manufactured with precision, sterility, and in accordance
with best manufacturing standards—and delivered to our customers.

Pentobarbital Sodium
for Injection, USP

Therapeutic Category:
Sedative-Hypnotic/Anxiolytic

  • AP Rated
  • Does Not Contain Natural Rubber Latex
  • Bar Coded
  • Preservative Free
See Details

Fludarabine Phosphate
for Injection, USP

Therapeutic Category:
Antineoplastic Agent

  • AP Rated
  • Does Not Contain Natural Rubber Latex
  • Bar Coded
  • Preservative Free
See Details

Leadership

We have assembled an executive team with deep experience in the healthcare industry. We’re ready to take Leucadia Pharmaceuticals to the next level.

William (Bill) has more than 23 years of experience in the pharmaceutical industry. Prior to joining Custopharm, Bill was vice president and general manager of Bedford Laboratories, Inc., where he oversaw a portfolio of more than 100 registered generic injectable products. Previously, he was senior director of product development at Amylin Pharmaceuticals Inc., where he managed development activities for proprietary peptide and protein injectable products. Bill also held positions at Novartis, ESI-Lederle, Barr Laboratories, Inc. and Schein Pharmaceutical, Inc. He began his career as an analytical research chemist. Bill received a doctorate degree in analytical chemistry from The Ohio State University and a bachelor’s degree in chemistry from Purdue University.

Kara Eiseman has more than 15 years of experience in the pharmaceutical industry. Before joining Leucadia Pharmaceuticals, Kara was Vice President of National Accounts for WG Critical Care, a generic injectables company. Kara was also Director of Marketing for Bioniche Pharma, which was acquired by Mylan in 2010. Kara also held marketing positions at APP Pharma (now Fresenius Kabi) and Akorn Pharmaceuticals. Kara received her MBA and MS in marketing from Loyola University Chicago, and her BA in economics from Northwestern University.

William Larkins, PhD
Chief Executive Officer

William (Bill) has more than 23 years of experience in the pharmaceutical industry. Prior to joining Custopharm, Bill was vice president and general manager of Bedford Laboratories, Inc., where he oversaw a portfolio of more than 100 registered generic injectable products. Previously, he was senior director of product development at Amylin Pharmaceuticals Inc., where he managed development activities for proprietary peptide and protein injectable products. Bill also held positions at Novartis, ESI-Lederle, Barr Laboratories, Inc. and Schein Pharmaceutical, Inc. He began his career as an analytical research chemist. Bill received a doctorate degree in analytical chemistry from The Ohio State University and a bachelor’s degree in chemistry from Purdue University.

Kara Eiseman
VP Sales & Marketing

Kara Eiseman has more than 15 years of experience in the pharmaceutical industry. Before joining Leucadia Pharmaceuticals, Kara was Vice President of National Accounts for WG Critical Care, a generic injectables company. Kara was also Director of Marketing for Bioniche Pharma, which was acquired by Mylan in 2010. Kara also held marketing positions at APP Pharma (now Fresenius Kabi) and Akorn Pharmaceuticals. Kara received her MBA and MS in marketing from Loyola University Chicago, and her BA in economics from Northwestern University.

Customer Service

If you need assistance, please contact us via phone at 844-538-2231 or email at info@leucadiapharma.com.